ASH 2021 packed with practice-changing hematologic cancer data

In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of

Myeloma patients have an increased risk of severe COVID-19. MGUS, the precursor of myeloma, has previously been associated with an increased risk of infections, the

International Myeloma Foundation press release: iStopMM charts the way forward in Myeloma research and treatment. This year, iStopMM presents four oral abstracts and two posters